Response: Chemotherapy Versus Allogeneic Transplantation in Adult Patients With Acute Lymphoblastic Leukemia in First Remission--Not a Time for Dogma

Blood - United States
doi 10.1182/blood-2013-05-498345
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Adults With Philadelphia-Like Acute Lymphoblastic Leukemia: Considerations for Allogeneic Hematopoietic Cell Transplantation in First Complete Remission

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Allogeneic Bone Marrow Transplantation for Patients With Acute Lymphoblastic Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
1983English

Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients With Intermediate-Risk Acute Myelogenous Leukemia in First Complete Remission

Clinical Cancer Research
Cancer ResearchOncology
2018English

Remission to Transplantation Time in Acute Myeloid Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Benefit of Allogeneic Transplantation in Patients Age ≥ 60 Years With Acute Myeloid Leukemia Is Limited to Those in First Complete Remission at Time of Transplant

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Allogeneic Hematopoietic Cell Transplantation in First Remission Abrogates Poor Outcomes Associated With High-Risk Pediatric Acute Myeloid Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Allogeneic Stem Cell Transplantation Outcomes in Acute Myeloid Leukemia Patients With T(8;21)(q22;q22) in First Remission According to Conditioning Regimen

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Haploidentical vs Autologous Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia Beyond First Remission

Bone Marrow Transplantation
TransplantationHematology
2003English

Inferior Outcome of Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in First Complete Remission as Compared to De Novo Acute Myeloid Leukemia

Blood Cancer Journal
OncologyHematology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy